Zantac, a medication used to treat heartburn and acid reflux, has been linked to severe health problems.
The Food and Drug Administration has issued a warning about the potential health risks associated with Zantac. These risks include cancer, birth defects, and other serious health problems.
Many heartburn sufferers have relied on Zantac and other generic ranitidine-containing brands to relieve the burning sensation typically caused by gastroesophageal reflux (GERD). However, when recent studies linked Zantac and other approved OTC products containing ranitidine to various forms of stomach cancer, the government pulled Zantac from retail shelves in the United States.
Were you diagnosed with Zantac OTC-related cancer, or did you lose a loved one from wrongful death? The personal injury attorneys at Rosenfeld Injury Lawyers, LLC can serve as your legal advocate to help you seek justice and the Zantac lawsuit payout you deserve.
Contact our Zantac cancer attorneys today at (888) 424-5757 (toll-free phone call) or through the contact form to schedule a free consultation. All information you share with our law offices remains confidential through an attorney-client relationship.
In early April 2020, the U.S. Food and Drug Administration FDA warned that Zantac ranitidine’s over-the-counter heartburn medication was unsafe. The FDA said this because all ranitidine products contain unacceptable levels of NDMA (N Nitrosodimethylamine).
When N Nitrosodimethylamine NDMA breaks down, ranitidine drugs can lead to cancer or probable human carcinogen if the levels of NDMA build up too much, so you should talk to a health care professional about prescriptions and the FDA recall.
Ever since the U.S. Food and Drug Administration said there might be health problems associated with Zantac and any ranitidine product, people started to consider filing Zantac cases and a Zantac cancer lawsuit.
The essential thrust of any Zantac cancer trials and lawsuits is that the N Nitrosodimethylamine N.D.M.A. in Zantac (a popular drug to treat heartburn or acid reflux sold over the counter) might give you cancer after taking it.
In April 2020, the Food and Drug Administration (FDA) warned that the popular heartburn medication, Zantac (ranitidine), should not be taken because of high levels of NDMA (N Nitrosodimethylamine NDMA) in Zantac medication. Ranitidine tablets are primarily taken for acid reflux, GERD, heartburn and other problems.
Did you know that Zantac is no longer available? In September 2019, the US Food and Drug Administration announced that it had identified an impurity in generic ranitidine manufactured and sold in the US.
This impurity is NDMA, a probable human carcinogen. The agency issued a recall of all products containing this ingredient, including Zantac and its generic counterparts.
People taking Zantac may wish to change to a different drug or treatment alternative to avoid potential health risks. The FDA is advising consumers of over-the-counter heartburn meds to stop taking the medication and dispose of any unused Zantac medications they have at home.
Patients taking prescription heartburn drugs should consult with their doctors before stopping the medication and pursuing other treatments. At Rosenfeld Injury Lawyers, LLC, our personal injury attorneys are currently investigating potential lawsuits against the manufacturers of Zantac and other medications.
Was your cancer diagnosis directly linked to taking Zantac or the generic ranitidine? Were you diagnosed with stomach cancer, bladder cancer, thyroid cancer, prostate cancer, esophageal cancer, kidney cancer, liver cancer, breast cancer, or another medical condition?
At Rosenfeld Injury Lawyers, LLC, our personal injury attorneys represent injured victims that took the prescription Zantac, over-the-counter Zantac, or other ranitidine products to treat gastroesophageal reflux disease (GERD) or other stomach issues.
Call our dangerous drug attorneys at (888) 424-5757 (toll-free phone number) or use the contact form today to schedule a free consultation.
Zantac is a medication that belongs to a class of drugs known as H2 blockers. These medications are used to treat heartburn, acid reflux, and GERD (gastroesophageal reflux disease).
The problem with this type of drug is that it can cause cancer. The CDC has identified NDMA as a probable human carcinogen causing cancer when inhaled or ingested in large amounts over long periods. This chemical was found within Zantac products sold in the United States between 1983 and 2019.
At the end of 2019, the U.S. EPA (Environmental Protection Agency) proposed amending the current control measure regulations involving Ethylene Oxide (ETO) emission standards for commercial sterilization facilities.
The hazardous chemicals amendment would help reduce the cancer-causing ETO toxic chemical emissions and other toxic substances at facilities emitting higher concentrations.
The increased risk can result in adverse health effects due to short and long-term human exposure to the harmful chemical at or nearby commercial sterilization facilities.
Personal Injury News & Developments